SYNTHESIS AND ANTITUMOR ACTIVITIES OF UNSYMMETRICALLY SUBSTITUTED 1,4-BIS[(AMINOALKYL)AMINO]ANTHRACENE-9,10-DIONES AND RELATED SYSTEMS

被引:22
作者
KRAPCHO, AP
LANDI, JJ
SHAW, KJ
PHINNEY, DG
HACKER, MP
MCCORMACK, JJ
机构
[1] UNIV VERMONT,DEPT CHEM,BURLINGTON,VT 05405
[2] UNIV VERMONT,DEPT PHARMACOL,BURLINGTON,VT 05405
关键词
D O I
10.1021/jm00158a008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1370 / 1373
页数:4
相关论文
共 28 条
[1]  
BOWDEN GT, 1985, CANCER RES, V45, P4915
[2]  
CHENG CC, 1873, Patent No. 142745
[3]  
CHENG CC, 1979, J PHARM SCI, V68, P939
[4]  
CHENG CC, 1983, PROGR MED CHEM, P20
[5]   MITOXANTRONE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY WITH SPECIAL ATTENTION TO CARDIOTOXICITY [J].
COLEMAN, RE ;
MAISEY, MN ;
KNIGHT, RK ;
RUBENS, RD .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06) :771-776
[6]   MITOXANTRONE - A REPLACEMENT FOR DOXORUBICIN [J].
CONNER, CS .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06) :479-480
[7]  
CORBETT TH, 1981, CANCER CHEMOTH PHARM, V6, P161
[8]   INTERACTION OF AMINOALKYLAMINOANTHRAQUINONES WITH DEOXYRIBONUCLEIC-ACID [J].
DOUBLE, JC ;
BROWN, JR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (07) :502-507
[9]  
Durr F.E., 1980, U.S. Pat., Patent No. [4.197.249, 4197249]
[10]  
HELLMANN K, 1983, CANCER TREAT REV, V10, P1